SIRION Biotech is now part of Revvity!
SIRION Biotech products and services are now part of the Revvity portfolio!
Approaches to Advance Viral Vector Development and Characterisation for Gene Therapy Applications – A Journey Through Vector Optimization
rAAV vectorology is being optimized to allow for highly specific expression and greater efficacy –...
SIRION Expedites AAV Production with Increased Lab Capacity
SIRION Biotech, a global supplier of high-quality AAV vectors, has expanded its staff to meet the...
SIRION Biotech signs new research and licensing agreement for AAV capsid development with US Biotech company!
SIRION Biotech has ongoing research and licensing agreements with several global pharma and biotech...
SIRION Biotech Passes ISO 9001:2015 Inspection!
ISO Certification requires ongoing audits to assure that the company is maintaining ISO standards...
LentiBOOST Now Used In More Than 35 Cell Therapy Clinical Trials!
SIRION Biotech's LentiBOOST Lentiviral Transduction Reagent is used in an ever-increasing number of...
Meet the SIRION Biotech team at ESGCT in Edinburgh!
Booth 61, Edinburgh International Conference Center, October 11 – 14, 2022
We have a great team...
